tert-Butyl N-(3-[(3-aminopropyl)(methyl)amino]propyl)carbamate, 95%, 250mg

2-((tert-Butoxycarbonyl)amino)-5-(trifluoromethyl)benzoic acid, 97%, 500mg

Ethyl 2-(triphenylphosphoranylidene)propanoate, 94.0%, 100g

Thalidomide-PEG2-C2-NH2 (TFA), 100mg

N,N-Dimethylpropanethioamide, 95.0%, 5g

(2S,3S)-3-(tert-Butyl)-4-(2,6-dimethoxyphenyl)-2-isopropyl-2,3-dihydrobenzo[d][1,3]oxaphosphole, 97%, 1g

Acido N-fenilantranilico, min 97%, pa, 50 g, confezione in plastica.

3-(1-((tert-Butoxycarbonyl)amino)ethyl)benzoic acid, 95.0%, 250mg

Methyl 3-methylbenzoylformate, 97.0%, 5g

2-bromo-N-(2,6-dimethylphenyl)butanamide, 5g

3'-Amino-biphenyl-4-carboxylic acid, 95.0%, 250mg

Ethyl 6-bromopyrazolo[1,5-a]pyridine-3-carboxylate, 95.0%, 1g

5-Bromo-2-methylthioanisole, 95%, 5g